A Rollover Study for Patients Who Participated in Other Romidepsin Protocols

Summary

This study is intended to provide access to Romidepsin for participants who received Romidepsin in other trials sponsored by Gloucester Pharmaceuticals or Celgene Corporation and for participants whom the investigator feels may benefit from continuing treatment with Romidepsin.

Timeline

Start

2011-05-01

Primary completion

2012-09-05

Completion

2012-09-05

Drugs

Indications